Diversity of Enrollment in Prostate Cancer Clinical Trials Current Status and Future Directions

Dr. Elisabeth Heath, Professor of Oncology & Medicine at Karmanos Cancer Institute presented Diversity of Enrollment in Prostate Cancer Clinical Trials: Current Status and Future Directions at PHEN’s 18th Annual African American Prostate Cancer Disparity Summit.

Elisabeth Heath, MD, FACP, Professor of Oncology & Medicine, Karmanos Cancer Institute co-authored a publication ‘Diversity of Enrollment in Prostate Cancer Clinical Trials: Current Status and Future Directions.’ “If you look at the numbers between 1995-2014, the trials had a decrease in population of African American men from 11.3 percent to 2.8 percent. Yikes! What is happening there?”